HemaSphere (Jun 2022)
P934: DARATUMUMAB + LENALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: A POST HOC ANALYSIS OF SUSTAINED MINIMAL RESIDUAL DISEASE NEGATIVITY FROM GRIFFIN
- C. Rodriguez,
- J. L. Kaufman,
- J. Laubach,
- D. W. Sborov,
- B. Reeves,
- A. Chari,
- R. Silbermann,
- L. J. Costa,
- L. D. Anderson, Jr,
- N. Nathwani,
- N. Shah,
- N. Bumma,
- A. Jakubowiak,
- R. Z. Orlowski,
- H. Pei,
- A. Cortoos,
- S. Patel,
- T. S. Lin,
- P. G. Richardson,
- P. M. Voorhees
Affiliations
- C. Rodriguez
- 1 Wake Forest University School of Medicine, Winston-Salem
- J. L. Kaufman
- 2 Winship Cancer Institute, Emory University, Atlanta
- J. Laubach
- 3 Dana-Farber Cancer Institute, Boston
- D. W. Sborov
- 4 Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City
- B. Reeves
- 5 University of North Carolina – Chapel Hill, Chapel Hill
- A. Chari
- 6 Tisch Cancer Institute, Mount Sinai School of Medicine, New York
- R. Silbermann
- 7 Knight Cancer Institute, Oregon Health & Science University, Portland
- L. J. Costa
- 8 University of Alabama at Birmingham, Birmingham
- L. D. Anderson, Jr
- 9 Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas
- N. Nathwani
- 10 Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte
- N. Shah
- 11 Department of Medicine, University of California San Francisco, San Francisco
- N. Bumma
- 12 Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus
- A. Jakubowiak
- 13 University of Chicago Medical Center, Chicago
- R. Z. Orlowski
- 14 Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
- H. Pei
- 15 Janssen Research & Development, LLC, Titusville
- A. Cortoos
- 16 Janssen Scientific Affairs, LLC, Horsham
- S. Patel
- 16 Janssen Scientific Affairs, LLC, Horsham
- T. S. Lin
- 16 Janssen Scientific Affairs, LLC, Horsham
- P. G. Richardson
- 3 Dana-Farber Cancer Institute, Boston
- P. M. Voorhees
- 17 Levine Cancer Institute, Atrium Health, Charlotte, United States of America
- DOI
- https://doi.org/10.1097/01.HS9.0000846604.67185.0c
- Journal volume & issue
-
Vol. 6
pp. 824 – 825
Abstract
No abstracts available.